The ACIP was scheduled to discuss COVID-19 vaccine injuries at a March meeting, potentially voting on future immunization recommendations.

The FDA proposed new guidelines for approving experimental therapies for rare diseases without large group studies.

A coalition of 15 states filed a suit to reverse federal decisions cutting the routinely recommended childhood vaccines from 17 to 11.

Biologic therapy during pregnancy was not associated with adverse outcomes for most patients in a retrospective study presented at AAAAI 2026.

The Trump administration proposed ACA rules to lower premiums by increasing out-of-pocket costs and high deductibles.

Research presented at AAAAI studied the relationship between race and patient characteristics in patients with CSU. Dr Mosnaim discussed the findings.

Dr Geng discusses his research from AAAAI Annual Meeting, which explored the relationship between atopic dermatitis and comorbid atopic conditions.

New data reveal that episodic lack of disease control in chronic spontaneous urticaria is linked to increased hospitalizations and outpatient visits.